Skip to content

APOTHEEK INNESTO

Active
Private limited companyfounded 2017active for 9 yearsLommelsesteenweg 217, 3970 Leopoldsburg, BelgiumKBO/BCE: BE 0671.774.785
Summary

APOTHEEK INNESTO has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €61,478 and a net result of €3,765. Equity fluctuates too strongly from year to year to read a trend from it. Its solvency ranks better than 22% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 1.3% (low).

Overview

Official details

Source: KBO
Status
Active since 23-02-2017 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.261.839.664 3970 Leopoldsburg, since 23-02-2017
Financial year end
31 December
Peppol
Reachable since 20-08-2025

Board and ownership

Board
  • InnestoDirector · permanent representative DEBRUYNE Katrien Karolien Leopoldine Marie

Financial position

64 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
1.3%
Annual accounts 2025
Gross margin
€198,508
▲ 10.8%
Turnover
≈ €930,000
estimated
Profit
€3,765
▼ 91.9%
Equity
€61,478
▲ 6.5%
Total assets
€545,442
▲ 12.2%
Employees on 31-12-2025
4
=
  • 2025 accounts filed 31 days after the deadline
Filed on 31-08-2026
Score breakdownraises riskLast filed accounts filed 31 days late; 2 of the last 3 accounts lateEquity €61,478 (11.3% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 2.3 FTE, total assets €545,442Show the evidence

Checked score

Score 2025
64 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially stronger than 37% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Weak
Solvency 36-1
equity 11.3% of total assets
Liquidity 18+11
short-term debt 88.4% · cash 13.5%
Profitability 70-11
return on assets 0.7%
Bankruptcy probability within 12 months
1.3% Low
0%0.5%1.5%4%10%≥ 25%

About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: 0.8% 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025lowest value 06-2025: 0.9%▲ +0.1 percentage points vs 05-2025 07-2025: 1.0%▲ +0.1 percentage points vs 06-2025 08-2025: 1.4%▲ +0.4 percentage points vs 07-2025 09-2025: 1.8%▲ +0.4 percentage points vs 08-2025 10-2025: 1.9%▲ +0.1 percentage points vs 09-2025 11-2025: 1.9%● unchanged vs 10-2025 12-2025: 1.9%● unchanged vs 11-2025 01-2026: 1.9%● unchanged vs 12-2025 02-2026: 1.9%● unchanged vs 01-2026 03-2026: 1.9%● unchanged vs 02-2026 04-2026: 1.9%● unchanged vs 03-2026 05-2026: 2.0%▲ +0.1 percentage points vs 04-2026 06-2026: 1.9%▼ -0.1 percentage points vs 05-2026 07-2026: 1.9%● unchanged vs 06-2026 08-2026: 2.3%▲ +0.4 percentage points vs 07-2026highest value 09-2026: 1.3%▼ -1.0 percentage point vs 08-2026 10-2026: 1.3%● unchanged vs 09-2026 11-2026: 1.3%● unchanged vs 10-2026
Credit of up to €3,500 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.02 (1.02 in 2024), below the usual 1.5. Short-term debt is 88.4% and cash 13.5% of total assets. 88.7% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 28% of them on solvency, 17% on liquidity, 51% on profitability and 55% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Seven signals.
lowers riskraises risk
raises risk · Last filed accounts filed 31 days late; 2 of the last 3 accounts late
NBB · filings
raises risk · Equity €61,478 (11.3% of total assets)
NBB · annual accounts
lowers risk · Size: 2.3 FTE, total assets €545,442
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 22% of 12757 sector peers (2025).
NBB · sector comparison
Position among 12757 sector peers
Solvency
better than 22%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €61,478
raises risk · 2025 accounts filed 31 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 8 filings
Deviation from the deadline
2025
31 days late
2024
57 days late
2023
20 days late
2022
14 days late
2021
17 days early
2020
13 days late
2019
44 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 11 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (4 of the last 5 accounts filed within 36 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Recent changes

  1. · Gazette deed Resignation: INNESTO (director)Reappointment: INNESTO (director) · Permanent representative: DEBRUYNE Katrien Karolien Leopoldine Marie
  2. · Gazette deed Incorporation
All 13 events

Comparable companies

These companies have the same main activity as APOTHEEK INNESTO: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €463,000 and €638,000, founded between 2013 and 2018.

CompanyTotal assetsGross margin
APOTHEEK INNESTO Leopoldsburg€545,442€198,508
PHARMACIE D'ICI - WOLUWE TOMBERG Sint-Lambrechts-Woluwe€619,619€207,985
Pharmacie Codden Manage€597,613€213,863
PHARMACIE TRIFFAUX Ham-sur-Heure-Nalinnes€462,949€169,541
Apotheek Decoster Dilsen-Stokkem€638,294€165,782
APOTHEEK BAUDOT Gingelom€488,618€286,516
PHARMACIE DANTOIN Liège€535,094€215,216
Full comparison

Key facts about APOTHEEK INNESTO

What is the company number of APOTHEEK INNESTO?
The company number of APOTHEEK INNESTO is 0671.774.785. The VAT number is the same number with BE in front: BE 0671.774.785.
Where is APOTHEEK INNESTO based?
The registered office is at Lommelsesteenweg 217, 3970 Leopoldsburg.Company details
What does APOTHEEK INNESTO do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK INNESTO?
The legal form of APOTHEEK INNESTO is Private limited company (BV).
When was APOTHEEK INNESTO founded?
APOTHEEK INNESTO was founded on 23-02-2017.
Is APOTHEEK INNESTO still active?
Yes, APOTHEEK INNESTO is an active enterprise in the KBO register.
How many employees does APOTHEEK INNESTO have?
APOTHEEK INNESTO had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK INNESTO fall under?
In its 2025 annual accounts, APOTHEEK INNESTO states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of APOTHEEK INNESTO?
The turnover in financial year 2025 is ≈ €930,000. This figure is estimated from the gross margin of €198,508 and 51 comparable companies (NACE 477). It probably lies between €630,000 and €1.8m.
Is APOTHEEK INNESTO profitable?
In financial year 2025, APOTHEEK INNESTO made a profit of €3,765.
Where can I find the annual accounts of APOTHEEK INNESTO?
APOTHEEK INNESTO filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK INNESTO due?
APOTHEEK INNESTO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.